vimarsana.com

Page 2 - சுந்டேக்க் ரியல்டீ வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Poly Medicure jumps on successfully raising funds via QIP issue

Poly Medicure rose 2.25% to Rs 665 after the company successfully raised Rs 400 crore through qualified institutional placement (QIP) route.Poly Medicure s QIP committee approved allotment of 76,33,587 equity shares to eligible qualified institutional buyers at the issue price of Rs 524 per equity share, aggregating to Rs 400 crore. The QIP issue opened on 15 February 2021 and closed on 18 February 2021. Allottees who were issued more than 5% of the total equity shares offered in the qualified institutions placement (QIP) are SMALLCAP World Fund (27.25%), Lighthouse India III Equity Investors (15.50%), UTI Mutual Fund (12.61%), Max Life Insurance Company (10%), Abu Dhabi Investment Authority (9.60%) and Ashoka India Opportunities Fund (5.95%). Poly Medicure proposes to utilize the net proceeds for funding suitable organic and inorganic growth opportunities, ongoing capital expenditure, other long term and short terms requirements, pre-payment and/or repayment of outstanding borrow

Realty in focus: Sunteck posts strong operational update, JP Morgan bullish on Indian real estate

Sunteck Realty Sees Growth In Pre Sales For Q3FY21

BW Businessworld Sunteck Realty Sees Growth In Pre-Sales For Q3FY21 SRL is one of the fastest-growing Mumbai-based luxury real estate development companies that reported Pre-sales for Q3 FY21 at Rs 349 crore; up by 75% QoQ and by 7% YoY Photo Credit : Sunteck Realty Limited (SRL), Mumbai’s premium real estate developer, announced its Q3 and 9M FY20-21 operational updates. SRL saw robust growth in Pre-sales for Q3 FY21 at Rs 349 crore; it was up by 75% QoQ and by 7% YoY as well. Collections also grew at 79% QoQ to Rs 252 crore for Q3 FY21 and by 52% YoY. As the operations resume post lockdown, the Company has continued its strong sales momentum, supported by its ready-to-move-in, nearing-ready inventory as well as newly launched projects. With the construction activity returning to pre-COVID levels, the Company remains focused on accelerating the project progress across the portfolio to offset the time lost on account of the ongoing pandemic. SRL recently launched the second t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.